<bill session="110" type="sr" number="305" updated="2013-07-19T22:15:41-04:00">
  <state datetime="2007-09-04">PASSED:SIMPLERES</state>
  <status>
    <unknown datetime="2007-09-04"/>
  </status>
  <introduced datetime="2007-08-03"/>
  <titles>
    <title as="introduced" type="official">A resolution to express the sense of the Senate regarding the Medicare national coverage determination on the treatment of anemia in cancer patients.</title>
  </titles>
  <sponsor id="300092"/>
  <cosponsors>
    <cosponsor id="300064" joined="2007-08-03"/>
    <cosponsor id="300051" joined="2007-08-03" withdrawn="2007-09-04"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2007-08-03">
      <text>Referred to the Committee on Finance.</text>
      <reference ref="CR S10943-10944" label="text of measure as introduced"/>
    </action>
    <action datetime="2007-09-04">
      <text>Senate Committee on Finance discharged by Unanimous Consent.</text>
      <reference ref="CR S11080-11081" label="consideration"/>
    </action>
    <vote state="PASSED:SIMPLERES" datetime="2007-09-04" how="by Unanimous Consent" result="pass" type="vote" where="s">
      <text>Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent.</text>
      <reference ref="CR S11080-11081" label="text"/>
    </vote>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" activity="Referral, Discharged"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Blood"/>
    <term name="Blood diseases"/>
    <term name="Cancer"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Medicare"/>
    <term name="Social welfare"/>
  </subjects>
  <amendments/>
  <summary>9/4/2007--Passed Senate without amendment.
Expresses the sense of the Senate that the Centers for Medicare &amp; Medicaid Services should: (1) begin an immediate reconsideration of the final National Coverage Determination on the Use of Erythropoiesis Stimulating Agents in Cancer and Related Neoplastic Conditions (CAG-000383N); (2) consult with members of the clinical oncology community to determine appropriate revisions to it: and (3) implement such revisions as soon as feasible, and brief Congress in advance of announcing such changes.</summary>
</bill>
